These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Prostaglandin I2 (prostacyclin). Kelton JG; Blajchman MA Can Med Assoc J; 1980 Jan; 122(2):175-9. PubMed ID: 6988063 [TBL] [Abstract][Full Text] [Related]
7. [Role of prostaglandins, thromboxanes and prostacyclin in regulating the thrombocyte aggregation process and liberation reaction normally and in pathology]. Baluda VP; Sushkevich GN; Lukoianova TI Patol Fiziol Eksp Ter; 1980; (4):80-5. PubMed ID: 6251418 [No Abstract] [Full Text] [Related]
8. 6-ketoprostaglandin E1 activates adenylate cyclase in human platelet membranes through prostacyclin receptors. Oliva D; Nicosia S Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 17():601-4. PubMed ID: 6328939 [No Abstract] [Full Text] [Related]
10. Prostacyclin is an autocrine regulator in the contraction of oviductal smooth muscle. Arbab F; Goldsby J; Matijevic-Aleksic N; Huang G; Ruan KH; Huang JC Hum Reprod; 2002 Dec; 17(12):3053-9. PubMed ID: 12456602 [TBL] [Abstract][Full Text] [Related]
11. Altered pain perception and inflammatory response in mice lacking prostacyclin receptor. Murata T; Ushikubi F; Matsuoka T; Hirata M; Yamasaki A; Sugimoto Y; Ichikawa A; Aze Y; Tanaka T; Yoshida N; Ueno A; Oh-ishi S; Narumiya S Nature; 1997 Aug; 388(6643):678-82. PubMed ID: 9262402 [TBL] [Abstract][Full Text] [Related]
12. 7-Oxabicyclo[2.2.1]heptane analogs as modulators of the thromboxane A2 and prostacyclin receptors. Sprague PW; Heikes JE; Harris DN; Greenberg R Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():337-43. PubMed ID: 6303073 [No Abstract] [Full Text] [Related]
13. [Pharmacology of prostacyclin and prostacyclin-like compounds]. Lakin KM; Baluda VP; Makarov VA Vestn Akad Med Nauk SSSR; 1982; (5):81-91. PubMed ID: 7048789 [No Abstract] [Full Text] [Related]
14. The antiaggregatory effectiveness of PGI2 and its binding to specific platelet receptors. A comparative study. Jaschonek K; Renn W; Weisenberger H Prog Clin Biol Res; 1987; 242():13-8. PubMed ID: 3313410 [No Abstract] [Full Text] [Related]
15. [Defects in the prostaglandin system. II. Familial platelet-prostacyclin receptor defect (Wien-Hietzing defect)--pathogenetic significance for (early) development of atherosclerosis?]. Kaliman J; Sinzinger H; Staudacher M; Mannheimer E Wien Klin Wochenschr; 1985 Mar; 97(7):323-6. PubMed ID: 2986363 [TBL] [Abstract][Full Text] [Related]
16. Blockage of partially obstructed coronary arteries with platelet thrombi: comparison between its prevention with cyclooxygenase inhibitors versus prostacyclin. Aiken JW; Shebuski RJ; Gorman RR Adv Prostaglandin Thromboxane Res; 1980; 7():635-9. PubMed ID: 6245568 [TBL] [Abstract][Full Text] [Related]
17. Receptors and mechanisms of action of prostacyclin in preserving non-mucosal cell integrity. Nicosia S; Oliva D; Paoletti R Gastroenterol Clin Biol; 1985; 9(12 Pt 2):33-6. PubMed ID: 2422088 [No Abstract] [Full Text] [Related]
18. Cardioprotective prostacyclin signaling in vascular smooth muscle. Fetalvero KM; Martin KA; Hwa J Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):109-18. PubMed ID: 17164138 [TBL] [Abstract][Full Text] [Related]
19. Role of prostacyclin in the cardiovascular response to thromboxane A2. Cheng Y; Austin SC; Rocca B; Koller BH; Coffman TM; Grosser T; Lawson JA; FitzGerald GA Science; 2002 Apr; 296(5567):539-41. PubMed ID: 11964481 [TBL] [Abstract][Full Text] [Related]